Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7541-7548

  Andreadis, S T ^a   Brott, D ^b   Fuller, A O ^a   Palsson, B O ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Aastrom Biosciences Inc   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; DERIVATIZATION; GENE TRANSFER; GENETIC STABILITY; HALF LIFE TIME; INTERNALIZATION; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENOME;

EID: 0030865201     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7541-7548.1997     Document Type: Article

References (36)

1. Anderson, W. F. 1992. Human gene therapy. Science 256:808-813.
2. Andreadis, S. 1996. Dynamics of retrovirus- mediated gene transfer. Ph.D. thesis. University of Michigan, Ann Arbor, Mich.
3. Andreadis, S., and B. O. Palsson. 1996. Kinetics of retrovirus-mediated gene transfer: the importance of intracellular half-life. J. Theor. Biol. 182:1-20.
4. 3a. Andreadis, S., A. O. Fuller, and B. O. Palsson. Cell cycle dependence of retroviral transduction: an issue of overlapping time scales. Biotech. Bioeng., in press.
5. Bader, J. P. 1970. Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment. Virology 40:494-504.
6. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
7. Brenner, M. K. 1993. Gene transfer into human hematopoietic progenitor cells: a review of current clinical protocols. J. Hematother, 2:7-17.
8. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356.
9. Brown, P. O. 1990. Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157:19-48.
10. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89:6580-6584.
11. Campisi, J., and E. E. Medrano. 1983. Cell cycle perturbations in normal and transformed fibroblasts caused by detachment from the substratum. J. Cell. Physiol. 114:53-60.
12. Chuck, A., and B. O. Palsson. 1996. Consistent and high rates of gene transfer can be obtained using the flow through transduction over a wide range of retroviral titers. Hum. Gene Ther. 7:743-750.
13. Chuck, A., and B. O. Palsson. 1996. Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 7:1527.
14. Coffin, J. M. 1990. Retroviridae and their replication, p. 645-708. In B. N. Fields and D. M. Knipe (ed.), Fundamental virology. Raven Press, New York, N.Y.
15. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
16. Danos, O., and R. C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85:6460-6464.
17. Fritsch, E. F., and H. M. Temin. 1977. Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J. Viral. 24:461-469.
18. Fujiwara, T., and R. Craigie. 1989. Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration. Proc. Natl. Acad. Sci. USA 86:3065-3069.
19. Harel, J., E. Rassart, and P. Jolicoeur. 1981. Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with Murine Leukemia Virus. Virology 110:202-207.
20. Hajihosseini, M., L. Lavachev, and J. Price. 1993. Evidence that retroviruses integrate into post-replication host DNA. EMBO J. 12:4969-4974.
21. Hodgson, C. P. 1995. The vector void in gene therapy. Bio/Technology 13:222-225.
22. Kotani, H., P. B. Newton III, S. Zhang, Y. L. Chiang, E. Otto, L. Weaver, R. M. Blaese, W. F. Anderson, and G. J. McGarrity. 1994. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5:19-28.
23. Layne, S., M. Merges, M. Dembo, J. Sponge, S. Conley, J. Moore, J. Raina, H. Renz, H. Gelderblom, and P. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
24. Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60S to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161.
25. Levin, J. G., and M. J. Rosenak. 1976. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc. Natl. Acad. Sci. USA 73:1154-1158.
26. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for human immunodeficiency virus. J. Virol. 68: 510-516.
27. Luciw, P. A., and N. J, Leung. 1992. Mechanisms of retroviral integration, p. 159-298. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, N.Y.
28. Miller, A. D. 1992. Human gene therapy comes of age. Nature 357:455-460.
29. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-1242.
30. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
31. Paul, R. W., D. Morris, B. W. Hess, J. Dunn, and R. W. Overell. 1993. Increased viral titer through concentration of viral harvests from retroviral packaging cell lines. Hum. Gene Ther. 4:609-615.
32. Roe, T. Y., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
33. Sanes, J. R., J. L. R. Rubenstein, and J. F. Nicolas. 1986. Use of a recombinant retrovirus to study post implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
34. Springett, G. M., R. C. Moen, S. Anderson, R. M. Blaese, and W. F. Anderson. 1989. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J. Virol. 63:3865-3869.
35. Varmus, H. E., T. Padgett, S. Heasley, G. Simon, and J. M. Bishop. 1997. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11:307-319.
36. 1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 82:5365-5369.